TuHURA Biosciences, Inc./NV
Pharmaceutical Preparations · TAMPA
Moderate confidence (50%)
Updated Oct 14, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: TuHURA Biosciences, Inc./NV received a delisting notice from its exchange (Jan 29, 2026)
Timeline
Every material event, newest first. History is never overwritten.
TuHURA Biosciences, Inc./NV received a delisting notice from its exchange
Jan 29, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 29, 2026, TuHURA Biosciences, Inc. (the Company ) received a letter from The Nasdaq Stock Market LLC ( Nasdaq ) indicating that the Company s consolidated closing bid price has been below $1.00 per share for 35 consecutive business days as of January 28, 2026, and that, therefore, the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which is the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The notice does not result in t…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker HURA on Nasdaq.
- SEC CIK
- 0001498382
- Website
- —
- —
- Headquarters
- TAMPA
- Also known as
- Berry Only Inc., DelMar Pharmaceuticals, Inc., Kintara Therapeutics, Inc.
- Legal entities
- TuHURA Biosciences, Inc./NV
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
TuHURA Biosciences, Inc./NV — Pharmaceutical Preparations (SIC 2834) — TAMPA, FL
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 29, 2026, TuHURA Biosciences, Inc. (the Company ) received a letter from The Nasdaq Stock Market LLC ( Nasdaq ) indicating that the Company s consolidated closing bid price has been below $1.00 per share for 35 consecutive business days as of January 28, 2026, and that, therefore, the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which is the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The notice does not result in t…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:04 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:02 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:04 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.